Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Disease Modifying Anti-rheumatic Drug (DMARD) But Not Responding.
Public ClinicalTrials.gov record NCT01197534. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
(OSKIRA-2): A Phase III, Multi-centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients With an Inadequate Response to DMARDs
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the effectiveness of two dosing regimens of fostamatinib compared to placebo, in patients with rheumatoid arthritis (RA) who are taking disease modifying anti-rheumatic drug (DMARD) but not responding. The study will last for 1 year.
Study identification
- NCT ID
- NCT01197534
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 913 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2010 (Type not available)
- Primary completion
- Mar 2013 (Actual)
- Completion
- Mar 2013 (Actual)
- Last update posted
- Apr 17, 2014
2010 – 2013
United States locations
- U.S. sites
- 57
- U.S. states
- 28
- U.S. cities
- 57
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | — | — |
| Research Site | Glendale | Arizona | — | — |
| Research Site | Mesa | Arizona | — | — |
| Research Site | Phoenix | Arizona | — | — |
| Research Site | Scottsdale | Arizona | — | — |
| Research Site | Tucson | Arizona | — | — |
| Research Site | Hot Springs | Arkansas | — | — |
| Research Site | Huntington Beach | California | — | — |
| Research Site | Torrance | California | — | — |
| Research Site | Trumbull | Connecticut | — | — |
| Research Site | Washington D.C. | District of Columbia | — | — |
| Research Site | Boca Raton | Florida | — | — |
| Research Site | Brandon | Florida | — | — |
| Research Site | Jacksonville | Florida | — | — |
| Research Site | Miami | Florida | — | — |
| Research Site | Orlando | Florida | — | — |
| Research Site | Tampa | Florida | — | — |
| Research Site | Venice | Florida | — | — |
| Research Site | Zephyrhills | Florida | — | — |
| Research Site | Canton | Georgia | — | — |
| Research Site | Decatur | Georgia | — | — |
| Research Site | Macon | Georgia | — | — |
| Research Site | Boise | Idaho | — | — |
| Research Site | South Bend | Indiana | — | — |
| Research Site | Elizabethtown | Kentucky | — | — |
| Research Site | Crofton | Maryland | — | — |
| Research Site | Cumberland | Maryland | — | — |
| Research Site | Hagerstown | Maryland | — | — |
| Research Site | Kalamazoo | Michigan | — | — |
| Research Site | Flowood | Mississippi | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Kalispell | Montana | — | — |
| Research Site | Omaha | Nebraska | — | — |
| Research Site | Manalapan | New Jersey | — | — |
| Research Site | Las Cruces | New Mexico | — | — |
| Research Site | Brooklyn | New York | — | — |
| Research Site | Rochester | New York | — | — |
| Research Site | Roslyn | New York | — | — |
| Research Site | Syracuse | New York | — | — |
| Research Site | Charlotte | North Carolina | — | — |
| Research Site | Durham | North Carolina | — | — |
| Research Site | Dayton | Ohio | — | — |
| Research Site | Duncansville | Pennsylvania | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | West Reading | Pennsylvania | — | — |
| Research Site | Greenville | South Carolina | — | — |
| Research Site | Orangeburg | South Carolina | — | — |
| Research Site | Memphis | Tennessee | — | — |
| Research Site | Amarillo | Texas | — | — |
| Research Site | Austin | Texas | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | Lubbock | Texas | — | — |
| Research Site | Mesquite | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Chesapeake | Virginia | — | — |
| Research Site | Tacoma | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 92 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01197534, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 17, 2014 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01197534 live on ClinicalTrials.gov.